ADMA Biologics Inc (ADMA) — Working Capital to Net Assets Ratio
ADMA Biologics Inc (ADMA) has a Working Capital to Net Assets ratio of 110.8% as of June 2026. Working capital of $452.45 Million (current assets of $528.20 Million minus current liabilities of $75.76 Million) is measured against net assets of $408.21 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ADMA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ADMA Biologics Inc Working Capital to Net Assets (2010–2025)
This chart shows how ADMA Biologics Inc's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of June 2026, the ratio stands at 110.8%, reflecting working capital of $452.45 Million against net assets of $408.21 Million USD. For the complete balance sheet picture, see balance sheet size of ADMA Biologics Inc.
Annual Working Capital to Net Assets for ADMA Biologics Inc (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ADMA Biologics Inc from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of ADMA Biologics Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 83.2% | $396.97 Million | $477.32 Million | $466.51 Million | $69.54 Million | ▲ +4.1 pp |
| 2024 | 79.0% | $275.87 Million | $349.02 Million | $331.41 Million | $55.54 Million | ▼ -74.2 pp |
| 2023 | 153.3% | $207.21 Million | $135.21 Million | $257.01 Million | $49.81 Million | ▲ +1.2 pp |
| 2022 | 152.1% | $231.13 Million | $151.97 Million | $270.40 Million | $39.27 Million | ▲ +25.8 pp |
| 2021 | 126.3% | $178.35 Million | $141.17 Million | $208.73 Million | $30.38 Million | ▼ -25.3 pp |
| 2020 | 151.6% | $133.79 Million | $88.25 Million | $153.74 Million | $19.95 Million | ▼ -122.5 pp |
| 2019 | 274.1% | $71.79 Million | $26.19 Million | $85.82 Million | $14.03 Million | ▲ +97.5 pp |
| 2018 | 176.5% | $34.90 Million | $19.77 Million | $44.53 Million | $9.63 Million | ▲ +43.3 pp |
| 2017 | 133.2% | $53.73 Million | $40.33 Million | $63.17 Million | $9.44 Million | ▲ +367.3 pp |
| 2016 | -234.1% | $10.43 Million | $-4.46 Million | $21.66 Million | $11.22 Million | ▼ -2313.8 pp |
| 2015 | 2079.7% | $17.07 Million | $820.97K | $21.29 Million | $4.22 Million | ▲ +1748.7 pp |
| 2014 | 331.0% | $19.89 Million | $6.01 Million | $24.09 Million | $4.20 Million | ▲ +204.0 pp |
| 2013 | 127.0% | $27.39 Million | $21.57 Million | $31.05 Million | $3.66 Million | ▼ -1.7 pp |
| 2012 | 128.7% | $12.13 Million | $9.42 Million | $13.95 Million | $1.82 Million | ▲ +28.7 pp |
| 2011 | 100.0% | $2.77K | $2.77K | $8.08K | $5.31K | ▲ +0.0 pp |
| 2010 | 100.0% | $-346.00 | $-346.00 | $12.01K | $12.36K | — |